Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB vs IGURATIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDELALISIB vs IGURATIMOD: Safety Overview

Metric IDELALISIB IGURATIMOD
Total FAERS Reports 6,862 286
Deaths Reported 1,548 51
Death Rate 22.6% 17.8%
Hospitalizations 2,962 179
Average Patient Age 70.0 yrs 67.9 yrs
% Female Patients 38.4% 71.6%
FDA Approval Date Jul 23, 2014 N/A
Manufacturer Gilead Sciences, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A